The implications and consequences of maternal obesity on fetal intrauterine growth restriction

L Radulescu1, O Munteanu, F Popa

  • 1Biochemistry Department, "Carol Davila" University of Medicine and Pharmacy, Bucharest.

Insights

Maternal obesity significantly increases risks for both mothers and newborns, leading to more intensive care needs and cesarean births. Early diagnosis of fetal growth restriction is crucial for managing these high-risk pregnancies.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Health
  • Public Health

Background:

  • Rising rates of maternal obesity (BMI ≥ 30 kg/m2) present significant health challenges.
  • Maternal obesity is linked to increased maternal and fetal complications, extending into childhood and adulthood.
  • Understanding these risks is critical for improving pregnancy outcomes.

Purpose of the Study:

  • To evaluate maternal and neonatal complications at birth in relation to maternal obesity.
  • To identify specific risks associated with obesity during pregnancy.

Main Methods:

  • Retrospective analysis of births at Bucharest University Emergency Hospital (2012).
  • Data collected on maternal obesity, complications, and neonatal status (birth weight, Apgar score, etc.).

Main Results:

  • Obese mothers had higher rates of intrauterine growth restriction (IUGR).
  • Increased need for neonatal intensive care, higher cesarean surgery rates, and thromboembolic complications were observed.
  • Complication severity correlated with the degree of maternal obesity.

Conclusions:

  • Pregnancy complications increase in number and severity with rising maternal obesity.
  • Early diagnosis and management of IUGR are vital for pregnancies affected by maternal obesity.
  • Close collaboration among obstetricians, family physicians, and neonatologists is essential.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
374
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
332